Background and aims Intralipid (ILP) has been demonstrated in animal models and humans to mitigate the cardio-depressant effects of local anesthetics and I/R injury, possibly via restoration of metabolic dysfunction, activation of cardio-protective signaling and augmentation of contractility.
Methods 8 adult female SD rats received a single intraperitoneal injection of LPS (20 mg/kg). Echocardiography was performed on the rats at baseline prior to injection of LPS, and then at 6h post-LPS, in order to assess LV ejection fraction. Rats were randomly divided to receive either 20% ILP (n=4) or phosphate buffered saline (PBS; n=4) as a 5 ml/kg bolus followed by a 0.5 ml/kg/min infusion over 10 min and echocardiography was conducted at 1, 5 and 10 min to reassess LVEF. At 10 min, LV tissue was collected and Western blots were performed to assess for GSK and STAT3 phosphorylation. Values are expressed as mean±SEM. P<0.05 is considered statistically significant.
Results Baseline LVEF in PBS and ILP before LPS were 75.7±1.1% and 74.2±1.2%, respectively. 6 h after LPS, LVEF was decreased (LVEF= 54.3±4.8% in PBS, and 46.0±2.5% in ILP; both p<0.05 vs. baseline). Rats treated with ILP had improved EF at 5 min (LVEF=63±3.9% p<0.05 vs.6h post LPS) that peaked at 10 min (LVEF=70.5±2.3%, p<0.05 vs.6h post LPS). PBS group had no significant improvement in LVEF at 5 and 10 min (LVEF=58.4±6.4% and 58.9±7.8%, respectively; both p=ns vs. 6h post LPS). Western blots demonstrated increased phosphorylation of STAT3 (∼2-fold) in ILP treated rats (p<0.05), not GSK phosphorylation.
Conclusions Administration of ILP significantly improves LVF likely mediated via STAT3 phosphorylation.
Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.